Finally, the hypolipidemic drug fenofibrate decreased Aβ expression, tau phosphorylation, and the serum Kallistatin level in KAL-TG mice, alleviating memory and cognitive impairment. The gene discussed is SERPINA4; the disease is Cognitive impairment.